509 related articles for article (PubMed ID: 17514620)
1. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.
Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G
J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Tanaka A; Kanazawa K; Ogura M; Ebuchi M; Takizawa T; Funata N; Fukayama M
Lab Invest; 1999 Sep; 79(9):1051-8. PubMed ID: 10496523
[TBL] [Abstract][Full Text] [Related]
3. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
[TBL] [Abstract][Full Text] [Related]
4. Are biochemical values predictive of adenoma's weight in primary hyperparathyroidism?
Hamidi S; Aslani A; Nakhjavani M; Pajouhi M; Hedayat A; Kamalian N
ANZ J Surg; 2006 Oct; 76(10):882-5. PubMed ID: 17007616
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.
Katai M; Sakurai A; Ikeo Y; Hashizume K
Horm Metab Res; 2001 Aug; 33(8):499-503. PubMed ID: 11544565
[TBL] [Abstract][Full Text] [Related]
7. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
8. Correlation of biochemical parameters with single parathyroid adenoma weight and volume.
Bindlish V; Freeman JL; Witterick IJ; Asa SL
Head Neck; 2002 Nov; 24(11):1000-3. PubMed ID: 12410535
[TBL] [Abstract][Full Text] [Related]
9. Calcium infusion in suspected hyperparathyroidism: changes in parathyroid hormone concentration related to histopathological findings.
Gillquist J; Larsson L; Lundström B; Eneström S; Kågedal B
Acta Chir Scand; 1979; 145(4):219-25. PubMed ID: 494968
[TBL] [Abstract][Full Text] [Related]
10. Genetic abnormalities in parathyroid nodules of uremic patients.
Chudek J; Ritz E; Kovacs G
Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
12. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
13. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
14. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
[TBL] [Abstract][Full Text] [Related]
15. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
[TBL] [Abstract][Full Text] [Related]
16. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism.
Marx SJ
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S19-24; discussion S31-2. PubMed ID: 1684885
[TBL] [Abstract][Full Text] [Related]
17. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
[TBL] [Abstract][Full Text] [Related]
18. GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism.
Kebebew E; Peng M; Wong MG; Ginzinger D; Duh QY; Clark OH
Surgery; 2004 Dec; 136(6):1261-6. PubMed ID: 15657585
[TBL] [Abstract][Full Text] [Related]
19. Correlation of intraoperative parathyroid hormone levels with parathyroid gland size.
Moretz WH; Watts TL; Virgin FW; Chin E; Gourin CG; Terris DJ
Laryngoscope; 2007 Nov; 117(11):1957-60. PubMed ID: 17891053
[TBL] [Abstract][Full Text] [Related]
20. Early postoperative function of suppressed parathyroid glands with microscopic hyperplasia.
Koivunen DG; Buick MK; Seaton JF; Harrison TS
Surgery; 1986 Dec; 100(6):1011-20. PubMed ID: 3787458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]